Cargando…
Midkine: The Who, What, Where, and When of a Promising Neurotrophic Therapy for Perinatal Brain Injury
Midkine (MK) is a small secreted heparin-binding protein highly expressed during embryonic/fetal development which, through interactions with multiple cell surface receptors promotes growth through effects on cell proliferation, migration, and differentiation. MK is upregulated in the adult central...
Autores principales: | Ross-Munro, Emily, Kwa, Faith, Kreiner, Jenny, Khore, Madhavi, Miller, Suzanne L., Tolcos, Mary, Fleiss, Bobbi, Walker, David W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642484/ https://www.ncbi.nlm.nih.gov/pubmed/33193008 http://dx.doi.org/10.3389/fneur.2020.568814 |
Ejemplares similares
-
Microglia-Mediated Neurodegeneration in Perinatal Brain Injuries
por: Fleiss, Bobbi, et al.
Publicado: (2021) -
Knowledge Gaps and Emerging Research Areas in Intrauterine Growth Restriction-Associated Brain Injury
por: Fleiss, Bobbi, et al.
Publicado: (2019) -
Midkine in Inflammation
por: Weckbach, Ludwig T., et al.
Publicado: (2011) -
Midkine: A Promising Molecule for Drug Development to Treat Diseases of the Central Nervous System
por: Muramatsu, Takashi
Publicado: (2011) -
Midkine’s Role in Cardiac Pathology
por: Woulfe, Kathleen C., et al.
Publicado: (2017)